17-DMAG Reduces Small Intestine Injury from Hemorrhage
Author Information
Author(s): Kiang Juliann G, Agravante Neil G, Smith Joan T, Bowman Phillip D
Primary Institution: Armed Forces Radiobiology Research Institute, Uniformed Services University
Hypothesis
Can 17-DMAG effectively reduce hemorrhage-induced injury in the small intestine?
Conclusion
17-DMAG may be a useful prophylactic drug for hemorrhage due to its ability to reduce injury in the small intestine.
Supporting Evidence
- 17-DMAG treatment significantly reduced hemorrhage-induced increases in iNOS protein.
- Treatment with 17-DMAG inhibited caspase-3 activation.
- 17-DMAG increased Bcl-2 protein levels in the small intestine.
- The study showed that hemorrhage increased TNF-α and IL-10 concentrations, which were inhibited by 17-DMAG.
Takeaway
This study found that a drug called 17-DMAG can help protect the small intestine from damage caused by bleeding.
Methodology
Mice were treated with 17-DMAG before inducing hemorrhage, and various biochemical and histological assessments were performed.
Limitations
The study was conducted in mice, which may not fully represent human responses.
Participant Demographics
Male Swiss Webster mice weighing 25-35 g were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website